Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques

References

• Bentzen SM. Quantitative clinical radiobiology. Acta Oncol 1993;32:259–75.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, . The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 2008;371:1098–107.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, . The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 2008;9:331–41.
   PubMed Web of Science ®Google Scholar
• Lukka H, Hayter C, Julian JA, Warde P, Morris WJ, Gospodarowicz M, . Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 2005;23:6132–8.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. High-tech in radiation oncology: Should there be a ceiling? Int J Radiat Oncol Biol Phys 2004;58:320–30.
   PubMed Web of Science ®Google Scholar
• Jin JY, Kong FM, Chetty IJ, Ajlouni M, Ryu S, Ten HR, . Impact of fraction size on lung radiation toxicity: Hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers. Int J Radiat Oncol Biol Phys 2010;76:782–8.
   PubMed Web of Science ®Google Scholar
• Rowell NP, O'rourke NP. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2004:CD002140.
   Google Scholar
• Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, . Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76:S70–S76.
   PubMed Web of Science ®Google Scholar
• Belderbos JS, Heemsbergen WD, De JK, Baas P, Lebesque JV. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:126–34.
   PubMed Web of Science ®Google Scholar
• Bradley J. A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group. Semin Oncol 2005;32(2 Suppl 3):S111–S113.
   Google Scholar
• Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, . High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:324–33.
   PubMed Web of Science ®Google Scholar
• Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, . Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000; 117:358–64.
   PubMed Web of Science ®Google Scholar
• Fowler JF. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol 2001;40:712–7.
   PubMed Web of Science ®Google Scholar
• Adkison JB, Khuntia D, Bentzen SM, Cannon GM, Tome WA, Jaradat H, . Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat 2008;7:441–7.
   PubMed Web of Science ®Google Scholar
• Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 1999;52:137–48.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Skoczylas JZ, Bernier J. Quantitative clinical radiobiology of early and late lung reactions. Int J Radiat Biol 2000;76:453–62.
   PubMed Web of Science ®Google Scholar
• Jackson A, Kutcher GJ, Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 1993; 20:613–25.
   PubMed Web of Science ®Google Scholar
• Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985;8: S13–S19.
   PubMedGoogle Scholar
• Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 1997;71:531–42.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys 2003; 30:979–85.
   PubMed Web of Science ®Google Scholar
• Ritter M. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol 2008;18:249–56.
   PubMedGoogle Scholar
• Ronde HS, Hoffmann L. Validation of Varian's AAA algorithm with focus on lung treatments. Acta Oncol 2009; 48:209–15.
   PubMed Web of Science ®Google Scholar
• Korreman SS, Juhler-Nottrup T, Fredberg PG, Navrsted PA, Enmark M, Nystrom H, . The role of image guidance in respiratory gated radiotherapy. Acta Oncol 2008;47:1390–6.
   PubMed Web of Science ®Google Scholar